Aby J. Mathew Biolife Solutions Inc (BLFS) insider trading activity

BLFS Quotes by TradingView

Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 263,119 shares of BLFS, which is worth approximately $6.95 Million. The most recent transaction as insider was on Mar 08, 2024, when has been sold 51,756 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K
17.18% 3M change
4.93% 12M change
Total Value Held $6.95 Million

Aby J. Mathew Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 08 2024
BUY
Grant, award, or other acquisition
-
51,756 Added 13.67%
326,970 Common Stock
Feb 21 2024
SELL
Open market or private sale
$1,752 $17.35 p/Share
101 Reduced 0.04%
275,214 Common Stock
Jan 19 2024
SELL
Open market or private sale
$24,302 $16.76 p/Share
1,450 Reduced 0.52%
275,315 Common Stock
Jan 02 2024
SELL
Open market or private sale
$11,674 $16.75 p/Share
697 Reduced 0.25%
276,765 Common Stock
Dec 17 2023
BUY
Grant, award, or other acquisition
-
705 Added 0.25%
276,666 Common Stock
Dec 03 2023
BUY
Grant, award, or other acquisition
-
796 Added 0.29%
277,462 Common Stock
Dec 01 2023
SELL
Open market or private sale
$7,310 $12.37 p/Share
591 Reduced 0.21%
275,961 Common Stock
Nov 19 2023
BUY
Grant, award, or other acquisition
-
826 Added 0.3%
276,552 Common Stock
Nov 13 2023
SELL
Open market or private sale
$1,421 $10.77 p/Share
132 Reduced 0.05%
275,726 Common Stock
Nov 05 2023
BUY
Grant, award, or other acquisition
-
924 Added 0.33%
275,858 Common Stock
Oct 22 2023
BUY
Grant, award, or other acquisition
-
1,034 Added 0.37%
274,934 Common Stock
Oct 08 2023
BUY
Grant, award, or other acquisition
-
779 Added 0.28%
273,900 Common Stock
Sep 28 2023
SELL
Open market or private sale
$9,331 $14.16 p/Share
659 Reduced 0.24%
273,121 Common Stock
Sep 24 2023
BUY
Grant, award, or other acquisition
-
802 Added 0.29%
273,780 Common Stock
Sep 10 2023
BUY
Grant, award, or other acquisition
-
792 Added 0.29%
272,978 Common Stock
Aug 27 2023
BUY
Grant, award, or other acquisition
-
966 Added 0.35%
272,186 Common Stock
Aug 25 2023
SELL
Open market or private sale
$5,703 $10.99 p/Share
519 Reduced 0.19%
271,220 Common Stock
Aug 14 2023
SELL
Open market or private sale
$2,228 $12.38 p/Share
180 Reduced 0.07%
271,739 Common Stock
Jul 20 2023
SELL
Open market or private sale
$200,700 $20.07 p/Share
10,000 Reduced 3.55%
271,919 Common Stock
Jul 20 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.43%
281,919 Common Stock
Jul 19 2023
SELL
Open market or private sale
$204,600 $20.46 p/Share
10,000 Reduced 3.55%
271,919 Common Stock
Jul 19 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.43%
281,919 Common Stock
Jun 27 2023
SELL
Open market or private sale
$15,922 $22.91 p/Share
695 Reduced 0.25%
271,919 Common Stock
Jun 22 2023
SELL
Open market or private sale
$233,200 $23.32 p/Share
10,000 Reduced 3.54%
272,614 Common Stock
Jun 22 2023
BUY
Exercise of conversion of derivative security
$20,600 $2.06 p/Share
10,000 Added 3.42%
282,614 Common Stock
AJM

Aby J. Mathew

EVP & Chief Scientific Officer
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BLFS